← Back to Search

Amino Acid-Based Supplement

amino acid-based blend for Fibromyalgia

N/A
Waitlist Available
Led By Susan Pekarovics, MD
Research Sponsored by Pekarovics, Susan, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks, 52 weeks
Awards & highlights

Study Summary

This study is evaluating whether a blend of amino acids may help improve symptoms of fibromyalgia.

Eligible Conditions
  • Fibromyalgia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks, 52 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks, 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in IGF-1
Secondary outcome measures
Blood pressure (systolic and diastolic)
Fasting HDL cholesterol
Fasting LDL cholesterol
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Amino acid-based blendExperimental Treatment1 Intervention
The amino acid-based blend will be administered PO daily for the study duration

Find a Location

Who is running the clinical trial?

Pekarovics, Susan, MDLead Sponsor
Susan Pekarovics, MDPrincipal InvestigatorPekarovics, Susan, MD

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~21 spots leftby Apr 2025